Search research articles
Contact Us
Filters
Showing results (21-30 of 45) with videos related to
Page
of 5
Sort By:
Lung Cancer Management
|
December 7, 2019
Stereotactic body radiation therapy versus fractionated radiation therapy for early-stage bronchopulmonary carcinoid
Rodney E Wegner, Stephen Abel, Zachary D Horne, et al.
Physics in Medicine and Biology
|
February 16, 2007
Dosimetric and technical aspects of intraoperative I-125 brachytherapy for stage I non-small cell lung cancer
Mark Johnson, Athanasios Colonias, David Parda, et al.
The Laryngoscope
|
May 24, 2019
Practice patterns and outcomes following radiation dose de-escalation for oropharyngeal cancer
Richard White, Stephen Abel, Shaakir Hasan, et al.
Lung Cancer (Amsterdam, Netherlands)
|
January 16, 2019
Stereotactic ablative radiotherapy (SABR) in early stage non-small cell lung cancer: Comparing survival outcomes in adenocarcinoma and squamous cell carcinoma
Stephen Abel, Shaakir Hasan, Richard White, et al.
Lung Cancer Management
|
January 16, 2019
SBRT for early stage lung cancer: outcomes from biopsy-proven and empirically treated lesions
Rodney E Wegner, Nissar Ahmed, Shaakir Hasan, et al.
Journal of Drugs in Dermatology : JDD
|
April 24, 2019
Grover’s Disease Treated With Total Skin Electron Beam Radiotherapy
Paul Renz, Shaakir Hasan, Joseph C. English, et al.
Advances in Radiation Oncology
|
July 26, 2017
Cryptic <i>Nocardia nova</i> brain abscess postradiation treatment and neurosurgery in a patient with small cell lung cancer: A case report and review of the literature
Stephen Abel, Shaakir Hasan, Brandon Kujawski, et al.
Lung Cancer (Amsterdam, Netherlands)
|
April 28, 2019
The role of adjuvant therapy for atypical bronchopulmonary carcinoids
Rodney E Wegner, Stephen Abel, Shaakir Hasan, et al.
Lung Cancer (Amsterdam, Netherlands)
|
August 27, 2019
Establishing a histology-specific biologically effective dose threshold for lung stereotactic ablative radiotherapy (SABR): Is ≥100 Gy<sub>10</sub> enough?
Stephen Abel, Shaakir Hasan, Vivek Verma, et al.
Brachytherapy
|
February 27, 2008
Tolerance of the aorta using intraoperative iodine-125 interstitial brachytherapy in cancer of the lung
Mark G Trombetta, Athanasios Colonias, Daryl Makishi, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 45) with videos related to
Sort By:
Page
of 5
Lung Cancer Management
|
December 7, 2019
Stereotactic body radiation therapy versus fractionated radiation therapy for early-stage bronchopulmonary carcinoid
Rodney E Wegner, Stephen Abel, Zachary D Horne, et al.
Physics in Medicine and Biology
|
February 16, 2007
Dosimetric and technical aspects of intraoperative I-125 brachytherapy for stage I non-small cell lung cancer
Mark Johnson, Athanasios Colonias, David Parda, et al.
The Laryngoscope
|
May 24, 2019
Practice patterns and outcomes following radiation dose de-escalation for oropharyngeal cancer
Richard White, Stephen Abel, Shaakir Hasan, et al.
Lung Cancer (Amsterdam, Netherlands)
|
January 16, 2019
Stereotactic ablative radiotherapy (SABR) in early stage non-small cell lung cancer: Comparing survival outcomes in adenocarcinoma and squamous cell carcinoma
Stephen Abel, Shaakir Hasan, Richard White, et al.
Lung Cancer Management
|
January 16, 2019
SBRT for early stage lung cancer: outcomes from biopsy-proven and empirically treated lesions
Rodney E Wegner, Nissar Ahmed, Shaakir Hasan, et al.
Journal of Drugs in Dermatology : JDD
|
April 24, 2019
Grover’s Disease Treated With Total Skin Electron Beam Radiotherapy
Paul Renz, Shaakir Hasan, Joseph C. English, et al.
Advances in Radiation Oncology
|
July 26, 2017
Cryptic <i>Nocardia nova</i> brain abscess postradiation treatment and neurosurgery in a patient with small cell lung cancer: A case report and review of the literature
Stephen Abel, Shaakir Hasan, Brandon Kujawski, et al.
Lung Cancer (Amsterdam, Netherlands)
|
April 28, 2019
The role of adjuvant therapy for atypical bronchopulmonary carcinoids
Rodney E Wegner, Stephen Abel, Shaakir Hasan, et al.
Lung Cancer (Amsterdam, Netherlands)
|
August 27, 2019
Establishing a histology-specific biologically effective dose threshold for lung stereotactic ablative radiotherapy (SABR): Is ≥100 Gy<sub>10</sub> enough?
Stephen Abel, Shaakir Hasan, Vivek Verma, et al.
Brachytherapy
|
February 27, 2008
Tolerance of the aorta using intraoperative iodine-125 interstitial brachytherapy in cancer of the lung
Mark G Trombetta, Athanasios Colonias, Daryl Makishi, et al.
Page
of 5